SANJAY NANNAPANENI's Insider Trades & SAST Disclosures
SANJAY NANNAPANENI's most recent trade in Natco Pharma Ltd. was a Acquisition of 286,910 Equity Shares done . Disclosure was reported to the exchange on March 27, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
SANJAY NANNAPANENI's has made SAST transactions in Natco Pharma Ltd. recently where a Acquisition of 40,000 shares done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | SANJAY NANNAPANENI | Promoter Group | Acquisition | 27 Mar 2025 | 286,910 | 326,910 (0.18%) | 0.16% | 0 | 0 | 26 Mar 2025 26 Mar 2025 |
Insider Trading | Equity Shares | Off Market |
| Natco Pharma | Sanjay Nannapaneni | Promoter | Acquisition | 26 Mar 2025 | 40,000 | 40,000 (0.02%) | 0.02% | - | 28 Feb 2025 28 Feb 2025 |
SAST (29(2)) | - | Transmission | |
| Natco Pharma | SANJAY NANNAPANENI | Promoter Group | Acquisition | 03 Mar 2025 | 40,000 | 40,000 (0.02%) | 0.02% | 0 | 0 | 28 Feb 2025 28 Feb 2025 |
Insider Trading | Equity Shares | Inheritance |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.